Immunogenicity and Safety of 13-valent Conjugated Pneumococcal Vaccine in Patients with Rheumatoid Arthritis
Relevance. Pneumococci are among the most common causative agents of severe bacterial infections in humans. The prevalence of invasive pneumococcal infections among people with autoimmune inflammatory rheumatic diseases is 3–4 times higher than in the general population. Aim. To evaluate the effecti...
Saved in:
| Main Authors: | B. T. Batozhargalova, M. P. Kostinov, A. D. Shmitko, G. V. Lukina, D. A. Murtazalieva, E. N. Koltsova, E. V. Zhilyaev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2024-03-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/1942 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity, safety and tolerability of 15-valent pneumococcal conjugate vaccine (V114) compared to 13-valent pneumococcal conjugate vaccine (PCV-13) in healthy infants: A systematic review and meta-analysis
by: Muhammad Zain Ul Haq, et al.
Published: (2025-06-01) -
Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine
by: M. P. Kostinov, et al.
Published: (2025-04-01) -
Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population
by: Charalampos Tzanetakos, et al.
Published: (2025-12-01) -
EXPERIENCE OF APPLICATION AND SAFETY ASSESSMENT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN UNDER-5 CHILDREN
by: M. V. Fedoseenko, et al.
Published: (2014-09-01) -
Immunogenicity of Pneumococcal Polysaccharide Vaccine in patients with rheumatoid arthritis
by: B. Ts. Batozhargalova, et al.
Published: (2024-09-01)